(Q38058746)

27 August 2017

title

Chronic lung allograft dysfunction after lung transplantation: the moving target (English)

1 reference

27 August 2017

1 reference

Masaaki Sato

1

1 reference

27 August 2017

publication date

10 November 2012

1 reference

General thoracic and cardiovascular surgery

27 August 2017

published in

1 reference

27 August 2017

volume

61

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

67-78

1 reference

https://scigraph.springernature.com/pub.10.1007/s11748-012-0167-3

27 August 2017

exact match

0 references

cites work

The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011.

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Bronchiolitis obliterans syndrome: alloimmune-dependent and -independent injury with aberrant tissue remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Upper lobe fibrosis: a novel manifestation of chronic allograft dysfunction in lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

21 January 2018

Bronchiolar disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Respiratory viruses and chronic rejection in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Innate immunity influences long-term outcomes after human lung transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Survival determinants in lung transplant patients with chronic allograft dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Thin-section computed tomography findings before and after azithromycin treatment of neutrophilic reversible lung allograft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Post-transplant bronchiolitis obliterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Bronchiolitis obliterans syndrome: the final frontier for lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Lymphoid neogenesis in chronic inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Lymphoid neogenesis in chronic rejection: the murderer is in the house.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

The role of intrapulmonary de novo lymphoid tissue in obliterative bronchiolitis after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Th17 cytokines and their emerging roles in inflammation and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

A Randomized Trial of Inhaled Cyclosporine in Lung-Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Long-term outcome after pulmonary retransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Quality of life and bronchiolitis obliterans syndrome in patients after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Palliative care--a shifting paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Early palliative care for patients with metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Palliative care referrals after lung transplantation in major transplant centers in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Perceptions and utilization of palliative care services in acute care hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-012-0167-3

Bronchoalveolar lavage neutrophilia in acute lung allograft rejection and lymphocytic bronchiolitis

21 January 2018

1 reference

12 December 2020

Unilateral lung transplantation for pulmonary fibrosis

1 reference

12 December 2020

Bronchiolitis obliterans syndrome after single-lung transplantation: impact of time to onset on functional pattern and survival

1 reference

12 December 2020

Psychological symptom levels and their correlates in lung and heart-lung transplant recipients.

1 reference

12 December 2020

Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation

1 reference

12 December 2020

Course of illness after the onset of chronic rejection in lung transplant recipients

1 reference

12 December 2020

Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome

1 reference

12 December 2020

Allograft airway fibrosis in the pulmonary milieu: a disorder of tissue remodeling

1 reference

12 December 2020

Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation

1 reference

12 December 2020

Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?

1 reference

12 December 2020

Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation

1 reference

12 December 2020

Why does inflammation persist: a dominant role for the stromal microenvironment?

1 reference

12 December 2020

Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome

1 reference

12 December 2020

A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.

1 reference

12 December 2020

An Official American Thoracic Society Clinical Policy Statement: Palliative Care for Patients with Respiratory Diseases and Critical Illnesses

1 reference

12 December 2020

Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction

1 reference

12 December 2020

The experience of the support person involved in a lung transplant programme: results of a pilot study

1 reference

12 December 2020

Stromal activation and formation of lymphoid-like stroma in chronic lung allograft dysfunction

1 reference

12 December 2020

Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction

1 reference

12 December 2020

10.1007/S11748-012-0167-3

Identifiers

DOI

1 reference

27 August 2017

1 reference